Use of statins in primary prevention of coronary artery disease: new data on risk-benefit balance
The article reviews current approaches to primary prevention of cardiovascular events and risk-benefit balance in the use of statin therapy in healthy people at risk of cardiovascular disease; the results of large clinical trials evaluating the efficacy of statins used for primary prevention; safety...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Remedium Group LLC
2013-12-01
|
| Series: | Медицинский совет |
| Subjects: | |
| Online Access: | https://www.med-sovet.pro/jour/article/view/950 |
| _version_ | 1797841914164150272 |
|---|---|
| author | S. R. Gilyarevskiy V. A. Orlov I. M. Kuzmina |
| author_facet | S. R. Gilyarevskiy V. A. Orlov I. M. Kuzmina |
| author_sort | S. R. Gilyarevskiy |
| collection | DOAJ |
| description | The article reviews current approaches to primary prevention of cardiovascular events and risk-benefit balance in the use of statin therapy in healthy people at risk of cardiovascular disease; the results of large clinical trials evaluating the efficacy of statins used for primary prevention; safety of statins, particularly, a higher risk of developing diabetes; different approaches to the selection of necessary and sufficient doses of statins in primary prevention. |
| first_indexed | 2024-04-09T16:39:13Z |
| format | Article |
| id | doaj.art-836a7454377140848b0ceef628e89b42 |
| institution | Directory Open Access Journal |
| issn | 2079-701X 2658-5790 |
| language | Russian |
| last_indexed | 2024-04-09T16:39:13Z |
| publishDate | 2013-12-01 |
| publisher | Remedium Group LLC |
| record_format | Article |
| series | Медицинский совет |
| spelling | doaj.art-836a7454377140848b0ceef628e89b422023-04-23T06:56:46ZrusRemedium Group LLCМедицинский совет2079-701X2658-57902013-12-0103929710.21518/2079-701X-2013-3-92-97950Use of statins in primary prevention of coronary artery disease: new data on risk-benefit balanceS. R. Gilyarevskiy0V. A. Orlov1I. M. Kuzmina2the N.V. Sklifosovsky Research Institute of Emergency Carethe N.V. Sklifosovsky Research Institute of Emergency Carethe N.V. Sklifosovsky Research Institute of Emergency CareThe article reviews current approaches to primary prevention of cardiovascular events and risk-benefit balance in the use of statin therapy in healthy people at risk of cardiovascular disease; the results of large clinical trials evaluating the efficacy of statins used for primary prevention; safety of statins, particularly, a higher risk of developing diabetes; different approaches to the selection of necessary and sufficient doses of statins in primary prevention.https://www.med-sovet.pro/jour/article/view/950первичная профилактикасердечнососудистые заболеваниястатиныprimary preventioncardiovascular eventsstatins |
| spellingShingle | S. R. Gilyarevskiy V. A. Orlov I. M. Kuzmina Use of statins in primary prevention of coronary artery disease: new data on risk-benefit balance Медицинский совет первичная профилактика сердечнососудистые заболевания статины primary prevention cardiovascular events statins |
| title | Use of statins in primary prevention of coronary artery disease: new data on risk-benefit balance |
| title_full | Use of statins in primary prevention of coronary artery disease: new data on risk-benefit balance |
| title_fullStr | Use of statins in primary prevention of coronary artery disease: new data on risk-benefit balance |
| title_full_unstemmed | Use of statins in primary prevention of coronary artery disease: new data on risk-benefit balance |
| title_short | Use of statins in primary prevention of coronary artery disease: new data on risk-benefit balance |
| title_sort | use of statins in primary prevention of coronary artery disease new data on risk benefit balance |
| topic | первичная профилактика сердечнососудистые заболевания статины primary prevention cardiovascular events statins |
| url | https://www.med-sovet.pro/jour/article/view/950 |
| work_keys_str_mv | AT srgilyarevskiy useofstatinsinprimarypreventionofcoronaryarterydiseasenewdataonriskbenefitbalance AT vaorlov useofstatinsinprimarypreventionofcoronaryarterydiseasenewdataonriskbenefitbalance AT imkuzmina useofstatinsinprimarypreventionofcoronaryarterydiseasenewdataonriskbenefitbalance |